Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.

Identification of disease severity remains a challenge in the management of non-alcoholic steatohepatitis (NASH). Cytokeratin-18 (CK18), is a recently developed non-invasive biomarker for NASH. We aimed to assess the performance of CK18 in disease severity prediction among Taiwanese NASH patients.A...

Full description

Bibliographic Details
Main Authors:	Jee-Fu Huang, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Pei-Chien Tsai, Chi-Ming Tai, Hua-Ling Yang, Chia-Yen Dai, Meng-Hsuan Hsieh, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long Chuang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5417412?pdf=render

Similar Items

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.
by: Jee-Fu Huang, et al.
Published: (2015-01-01)

Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients
by: Tyng‐Yuan Jang, et al.
Published: (2022-03-01)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
by: Ming-Lun Yeh, et al.
Published: (2023-10-01)

Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.
by: Wei Cao, et al.
Published: (2013-01-01)

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
by: Ming-Lun Yeh, et al.
Published: (2016-11-01)

Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population
by: Meng-Hsuan Hsieh, et al.
Published: (2012-09-01)

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
by: Akiko Eguchi, et al.
Published: (2022-08-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
by: Jee-Fu Huang, et al.
Published: (2020-01-01)

Necroptosis in Nonalcoholic Steatohepatitis
by: Jérémie Gautheron, PhD, et al.
Published: (2015-05-01)

Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients
by: Hua-Chien Wu, et al.
Published: (2023-05-01)

15-keto-PGE2 alleviates nonalcoholic steatohepatitis through its covalent modification of NF-κB factors
by: Siow-Wey Hee, et al.
Published: (2023-10-01)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
by: Po‐Yao Hsu, et al.
Published: (2022-01-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
by: Gopanandan Parthasarathy, et al.
Published: (2020-04-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment
by: Ming‐Lun Yeh, et al.
Published: (2019-10-01)

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.
by: Ying-Chou Huang, et al.
Published: (2021-01-01)

Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study
by: Lee Bai-Chin, et al.
Published: (2006-05-01)

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma
by: Ming-Lun Yeh, et al.
Published: (2015-02-01)

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection
by: Chung-Feng Huang, et al.
Published: (2015-05-01)

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
by: Ming-Lun Yeh, et al.
Published: (2017-01-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
by: Chuan-Pin Lin, et al.
Published: (2021-01-01)

Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis
by: Fei Xiong, et al.
Published: (2022-12-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort
by: Chung-Feng Huang, et al.
Published: (2023-06-01)

acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study
by: Xi-Xi Wu, et al.
Published: (2021-11-01)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2009)

Human Nonalcoholic Steatohepatitis on a Chip
by: May S. Freag, et al.
Published: (2021-02-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)

Uncovered issues in the overview of nonalcoholic steatohepatitis
by: Chia-Chi Wang
Published: (2011-12-01)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
by: Hui Xiang, et al.
Published: (2022-02-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

The regulatory state of nonalcoholic steatohepatitis and metabolism
by: Stephanie O. Omokaro, et al.
Published: (2020-10-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
by: S.M. Touhidul Islam, et al.
Published: (2020-09-01)

Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients
by: Jeng-Fu Yang, et al.
Published: (2009-08-01)

Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer.
by: Chung-Chieh Wang, et al.
Published: (2019-01-01)

Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse
by: Lishan Zhou, et al.
Published: (2017-11-01)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients
by: Ching-I Huang, et al.
Published: (2017-08-01)